3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 25.8 HKD 0.55% Market Closed
Market Cap: 62.8B HKD

Relative Value

The Relative Value of one 3SBio Inc stock under the Base Case scenario is hidden HKD. Compared to the current market price of 25.8 HKD, 3SBio Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

3SBio Inc Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
73
Median 3Y
2.1
Median 5Y
2.2
Industry
7.9
Forward
3
vs History
7
vs Industry
9
Median 3Y
8.8
Median 5Y
8.8
Industry
23.7
Forward
5.9
vs History
7
vs Industry
13
Median 3Y
7.5
Median 5Y
7.9
Industry
22
vs History
vs Industry
3
Median 3Y
9.5
Median 5Y
9.5
Industry
23.8
vs History
7
vs Industry
49
Median 3Y
1.2
Median 5Y
1.2
Industry
3.3
vs History
7
vs Industry
67
Median 3Y
1.7
Median 5Y
1.8
Industry
8.3
Forward
2.7
vs History
7
vs Industry
67
Median 3Y
2
Median 5Y
2.2
Industry
10.1
vs History
7
vs Industry
13
Median 3Y
4.7
Median 5Y
5
Industry
6.4
Forward
4
vs History
7
vs Industry
11
Median 3Y
5.3
Median 5Y
6
Industry
7
Forward
4.2
vs History
7
vs Industry
14
Median 3Y
5.8
Median 5Y
6.4
Industry
8.3
vs History
36
vs Industry
9
Median 3Y
9.6
Median 5Y
12.1
Industry
6.5
vs History
7
vs Industry
57
Median 3Y
0.8
Median 5Y
0.8
Industry
5.7

Multiples Across Competitors

Competitors Multiples
3SBio Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
3SBio Inc
HKEX:1530
60.9B HKD 6.1 23.4 16.7 19.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 770 229.5 -160 504.9 -194 904.1 -192 680.1
US
Abbvie Inc
NYSE:ABBV
396.1B USD 6.6 168.7 16.3 23.2
US
Amgen Inc
NASDAQ:AMGN
176.6B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
148.6B USD 5.1 18.3 12.3 12.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD 9.8 31.4 23 24.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.1 -532.3 -579.6 -564.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD 5.5 17.2 16.4 18.6
AU
CSL Ltd
ASX:CSL
84B AUD 3.6 18.5 12.5 15.6
NL
argenx SE
XBRU:ARGX
45.1B EUR 14.7 34.6 59.7 61.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.2B USD 16.3 1 198.5 157.4 190.9
P/S Multiple
Revenue Growth P/S to Growth
CN
3SBio Inc
HKEX:1530
Average P/S: 3 070 217.1
6.1
11%
0.6
FR
Pharnext SCA
OTC:PNEXF
33 770 229.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.8
10%
1
US
E
Epizyme Inc
F:EPE
2 086.1
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
14.7
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.3
46%
0.4
P/E Multiple
Earnings Growth PEG
CN
3SBio Inc
HKEX:1530
Average P/E: 170.7
23.4
18%
1.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 504.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
9%
1.9
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
NL
argenx SE
XBRU:ARGX
34.6
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 198.5
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
3SBio Inc
HKEX:1530
Average EV/EBITDA: 37
16.7
15%
1.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 904.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
NL
argenx SE
XBRU:ARGX
59.7
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
157.4
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
3SBio Inc
HKEX:1530
Average EV/EBIT: 42.7
19.7
17%
1.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 680.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
13%
1.4
AU
CSL Ltd
ASX:CSL
15.6
11%
1.4
NL
argenx SE
XBRU:ARGX
61.4
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
190.9
N/A N/A